Orange Shield: Revolutionizing IVF Financing and Family Planning
Table of Contents
For decades, couples undergoing in vitro fertilization (IVF) have faced a significant financial burden, frequently enough spending tens of thousands of dollars on procedures with no guarantee of success. This emotionally and financially draining process is now seeing a potential game-changer with the launch of orange Shield,a new IVF insurance product from san Francisco-based startup Future Family.
Backed by Munich Re Ventures,the venture arm of global reinsurer Munich Re,Orange Shield provides a money-back guarantee,likened by CEO and co-founder Claire Tomkins to trip insurance. Couples pay 20% upfront before starting an IVF cycle. If they don’t have a baby after two cycles or experience a loss within two weeks of birth, they can file a claim for reimbursement.
The cost of two IVF cycles can reach $40,000, depending on location. Orange Shield offers protection with an average cost of $3,000 down payment and $999 per month for five months. Our goal is simple: to help build more families by making IVF triumphant, easy to afford, and less stressful,
said Tomkins, a mother of three children born through IVF. IVF insurance works like other types of insurance — similar to auto insurance, where you purchase coverage hoping you won’t need to file a claim.
available at participating clinics nationwide, families can pay via monthly installments or a lump sum. The policy covers all IVF-related expenses up to a $50,000 maximum coverage limit. All eligible treatment costs are included.
Eligibility is steadfast by several underwriting factors, including age and medical history. Currently,patients aged 38 or older using their own eggs are ineligible,although those using donor eggs can qualify. Other factors include lifestyle habits like tobacco use, intended egg/sperm sources, and infertility history.
Since its founding in 2016, future Family has assisted over 10,000 families, providing fertility financing for IVF and egg freezing, along with one-on-one coaching. The company has distributed $200 million in credit and secured $150 million in funding, including a $100 million credit facility in 2018 and a $25 million Series B round in April 2022. Investors include Munich Re Ventures, TriVentures, MS&AD ventures, ORIX, Aspect Ventures, Mindset Ventures, at.inc/, and OurCrowd.
The IVF market is attracting increasing attention from startups. Recently, Lushi, a new fertility wellness company, secured $5 million in funding.
Orange Shield represents a significant growth in addressing the financial challenges associated with IVF, offering a new level of security and support for couples embarking on this journey.
Revolutionizing IVF: how Orange Shield is Transforming Family Planning
Orange Shield’s innovative approach addresses the significant financial barriers many couples face when pursuing IVF. The program’s structure, with its manageable payment plan and money-back guarantee, significantly reduces the financial risk and emotional stress associated with the process. This allows couples to focus on the emotional and physical aspects of treatment, rather than the overwhelming financial burden.
The Rising Costs of IVF: A Financial Obstacle
The high cost of IVF, potentially reaching $40,000 for two cycles, presents a major hurdle for many couples. Orange Shield directly tackles this issue by offering a more affordable and predictable payment structure. The upfront cost of 20% and the monthly installments make the process more accessible to a wider range of individuals.
The Benefits of Comparing Orange Shield to Other Insurance Models
The comparison to trip or auto insurance highlights the proactive nature of Orange Shield. It’s a form of financial preparedness, offering peace of mind rather than solely reacting to unforeseen expenses. The manageable payment plan further enhances its accessibility and affordability.
Inclusivity and Accessibility: Broadening the Reach
While current eligibility criteria exclude some groups, such as women over 38 using their own eggs, Future Family’s commitment to ongoing evaluation and improvement suggests a future with broader inclusivity. The company’s history of supporting over 10,000 families demonstrates a dedication to expanding access to fertility treatments.
Supporting Broader IVF Industry Trends
Orange Shield’s success is intertwined with Future Family’s broader vision for the fertility market. The company’s significant funding and investor base position it as a leader in the industry, driving innovation and accessibility in IVF financing.
Conclusion
Orange Shield represents a significant advancement in IVF financing, offering a new level of financial security and emotional support for couples. By making IVF more accessible and less financially daunting, Future Family is helping to make the dream of parenthood a reality for many.
Headline:
“Revolutionizing IVF Financing: How Orange Shield is Spearheading a New Era in Family Planning”
Opening Statement:
Wiht the cost of IVF routinely reaching tens of thousands of dollars, Orange Shield is breaking the mold by offering a transformative financing model that ensures a safer financial journey for aspiring parents. But what does this mean for couples struggling with IVF expenses? Let’s delve into the intricate dynamics of this groundbreaking initiative.
Senior editor: How is Orange shield redefining the financial landscape for couples undergoing IVF, and what makes this insurance model unique compared to conventional options?
Expert Response:
Orange Shield stands out by addressing a critical pain point in family planning: the financial risk and uncertainty associated with IVF. Similar to how trip or auto insurance allows individuals to safeguard against potential losses,Orange shield offers a money-back guarantee and structured payment plans. Couples pay an initial 20% before starting their IVF cycle, easing the financial burden substantially. if, after two cycles, they don’t achieve pregnancy or experience a miscarriage within two weeks of birth, they are eligible for substantial reimbursement. this model is transformative because it lowers financial barriers, allowing more couples to pursue IVF without the daunting fear of upfront costs.By offering monthly installments—$999 over five months in addition to a $3,000 down payment—Orange Shield is making IVF not just attainable but enduring for families nationwide.
moreover, with the backing of Munich Re Ventures and a sizeable investor network, Orange shield has solid financial backing to support claims and expand services, ensuring reliability and trustworthiness. This approach significantly reduces emotional stress, giving couples the confidence to focus on treatment outcomes rather than financial concerns.
Senior Editor: What are the key eligibility criteria for Orange Shield, and how do these parameters affect potential applicants?
Expert Response:
The eligibility criteria for Orange Shield were intentionally designed to ensure a reasonable risk assessment for the insurer while maximizing accessibility. Couples must meet specific age and medical history standards to qualify.as an example, women aged 38 or older using their own eggs currently face disqualification. This is due to statistically lower success rates in IVF treatments at advanced maternal ages using personal eggs rather than donor eggs. Other factors considered include lifestyle habits such as tobacco use, the source of eggs or sperm, and the couple’s infertility history.
These criteria,though seemingly restrictive,are in place to ensure the program’s financial viability and success rates. However, Future Family is committed to evolving these standards, striving to expand inclusion and support a broader range of families over time. This focus on continuous improvement highlights their dedication to increasing accessibility while maintaining program integrity.
senior Editor: could you discuss the broader impact of initiatives like Orange Shield and how they tie into the trends driving innovation in the IVF industry?
Expert Response:
Initiatives like orange Shield are fundamentally altering the IVF landscape by making the process more inclusive and financially viable. As IVF costs reach upwards of $40,000 for just two cycles, innovative financing models are a game-changer for prospective parents. Orange Shield is a part of a larger trend where startups recognize the unmet financial needs in fertility treatments and are stepping in to provide viable solutions. By offering financial security through insurance-like models, such programs reduce the emotional and economic barriers to accessing IVF.
This mirrors broader shifts in the fertility market, where other startups, like Lushi, are also striving to make treatments more accessible and supportive. With $150 million raised, Future Family is leading this charge, backed by a robust network of investors. Their focus on fertility financing exemplifies how targeted financial innovations can drive industry growth, improve accessibility, and ultimately help hundreds of thousands of families achieve their dreams of parenthood.
As these financial models gain traction, they contribute to a broader acceptance and normalization of IVF, encouraging more couples to consider it as a viable option without fear of economic hardship.
Conclusion:
Orange Shield represents a significant milestone in the personal and financial journey of aspiring parents, transforming how the IVF industry approaches accessibility and affordability. by offering a robust safety net, Future Family is not only assisting thousands of individuals but is also pioneering a shift towards a more inclusive and economically feasible approach to family planning. This progressive move invites conversation and further advancement within the industry, promising brighter futures for countless families.
we invite readers to weigh in on these exciting developments. How do you think innovative financing models like Orange Shield will impact the future of IVF? Share your thoughts in the comments below or on social media!